

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24028329 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24028329 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.23513674 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.23513674 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.10810317 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.10810317 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85680039 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 3.83976482 |
| 9 | lysine metabolic process (GO:0006553) | 3.80494120 |
| 10 | lysine catabolic process (GO:0006554) | 3.80494120 |
| 11 | pinocytosis (GO:0006907) | 3.78125056 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 3.76870901 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 3.76870901 |
| 14 | cysteine metabolic process (GO:0006534) | 3.74943070 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.68136620 |
| 16 | glyoxylate metabolic process (GO:0046487) | 3.65367948 |
| 17 | tryptophan catabolic process (GO:0006569) | 3.64132609 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 3.64132609 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 3.64132609 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62488121 |
| 21 | kynurenine metabolic process (GO:0070189) | 3.56246172 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 3.51863092 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.47950905 |
| 24 | tryptophan metabolic process (GO:0006568) | 3.45955075 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 3.41107836 |
| 26 | urea cycle (GO:0000050) | 3.39589476 |
| 27 | urea metabolic process (GO:0019627) | 3.39589476 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.35977243 |
| 29 | valine metabolic process (GO:0006573) | 3.34545571 |
| 30 | proline biosynthetic process (GO:0006561) | 3.33395291 |
| 31 | serine family amino acid biosynthetic process (GO:0009070) | 3.31794000 |
| 32 | GDP-mannose metabolic process (GO:0019673) | 3.22136862 |
| 33 | glycine metabolic process (GO:0006544) | 3.22040704 |
| 34 | protein maturation by protein folding (GO:0022417) | 3.21273752 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.19608864 |
| 36 | negative regulation of fibrinolysis (GO:0051918) | 3.19013182 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.17338691 |
| 38 | protein carboxylation (GO:0018214) | 3.17338691 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.15450084 |
| 40 | NIK/NF-kappaB signaling (GO:0038061) | 3.14985319 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 3.12504966 |
| 42 | complement activation, alternative pathway (GO:0006957) | 3.11707776 |
| 43 | regulation of superoxide anion generation (GO:0032928) | 3.10118323 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 3.05751971 |
| 45 | serine family amino acid metabolic process (GO:0009069) | 3.05478552 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 3.01729268 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 3.01383048 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 3.01372588 |
| 49 | response to peptidoglycan (GO:0032494) | 3.00758792 |
| 50 | mannose metabolic process (GO:0006013) | 2.94303057 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 2.91842745 |
| 52 | negative regulation of sterol transport (GO:0032372) | 2.91842745 |
| 53 | regulation of protein activation cascade (GO:2000257) | 2.90560771 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 2.89010811 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.88062759 |
| 56 | pentose-phosphate shunt (GO:0006098) | 2.87500835 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 2.86476257 |
| 58 | aldehyde catabolic process (GO:0046185) | 2.83834385 |
| 59 | ribosomal small subunit biogenesis (GO:0042274) | 2.82293836 |
| 60 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.80959852 |
| 61 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.80686435 |
| 62 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.80686435 |
| 63 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.80449465 |
| 64 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.80449465 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77091920 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 2.76466421 |
| 67 | regulation of complement activation (GO:0030449) | 2.76195935 |
| 68 | phospholipid efflux (GO:0033700) | 2.76021951 |
| 69 | regulation of fibrinolysis (GO:0051917) | 2.71994342 |
| 70 | modulation by virus of host process (GO:0019054) | 2.70340689 |
| 71 | L-serine metabolic process (GO:0006563) | 2.70129388 |
| 72 | protein retention in ER lumen (GO:0006621) | 2.69608528 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 2.69300172 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 2.69300172 |
| 75 | macromolecular complex remodeling (GO:0034367) | 2.69300172 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 2.68690797 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 2.67867293 |
| 78 | urate metabolic process (GO:0046415) | 2.67682894 |
| 79 | regulation of cholesterol homeostasis (GO:2000188) | 2.67477973 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 2.67149664 |
| 81 | amyloid precursor protein catabolic process (GO:0042987) | 2.66105404 |
| 82 | alpha-amino acid catabolic process (GO:1901606) | 2.65723746 |
| 83 | glycosphingolipid catabolic process (GO:0046479) | 2.64774749 |
| 84 | reverse cholesterol transport (GO:0043691) | 2.63444436 |
| 85 | ethanol oxidation (GO:0006069) | 2.63179219 |
| 86 | NADH metabolic process (GO:0006734) | 2.62957605 |
| 87 | modulation by symbiont of host cellular process (GO:0044068) | 2.62766685 |
| 88 | UV protection (GO:0009650) | 2.62232217 |
| 89 | NADPH regeneration (GO:0006740) | 2.62010972 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60531975 |
| 91 | glucose catabolic process (GO:0006007) | 2.59031328 |
| 92 | bile acid metabolic process (GO:0008206) | 2.58567771 |
| 93 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.57546059 |
| 94 | complement activation, classical pathway (GO:0006958) | 2.57123982 |
| 95 | heme metabolic process (GO:0042168) | 2.57119600 |
| 96 | protein-lipid complex assembly (GO:0065005) | 2.54661787 |
| 97 | complement activation (GO:0006956) | 2.53788583 |
| 98 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.53409245 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53078431 |
| 100 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.52313190 |
| 101 | immunoglobulin mediated immune response (GO:0016064) | 2.51687426 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.50861228 |
| 103 | heme biosynthetic process (GO:0006783) | 2.50515715 |
| 104 | tyrosine metabolic process (GO:0006570) | 2.50221117 |
| 105 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.49794092 |
| 106 | glycolipid catabolic process (GO:0019377) | 2.49750642 |
| 107 | benzene-containing compound metabolic process (GO:0042537) | 2.49089849 |
| 108 | disruption of cells of other organism (GO:0044364) | 2.47365199 |
| 109 | killing of cells of other organism (GO:0031640) | 2.47365199 |
| 110 | proline metabolic process (GO:0006560) | 2.47017712 |
| 111 | cellular amino acid catabolic process (GO:0009063) | 2.47016605 |
| 112 | cofactor catabolic process (GO:0051187) | 2.46143108 |
| 113 | aspartate family amino acid catabolic process (GO:0009068) | 2.45184785 |
| 114 | carnitine metabolic process (GO:0009437) | 2.44961103 |
| 115 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44761936 |
| 116 | modulation by symbiont of host defense response (GO:0052031) | 2.44761936 |
| 117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44761936 |
| 118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44761936 |
| 119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44761936 |
| 120 | modulation by symbiont of host immune response (GO:0052553) | 2.44761936 |
| 121 | drug transport (GO:0015893) | 2.44599096 |
| 122 | drug transmembrane transport (GO:0006855) | 2.44267490 |
| 123 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.43105218 |
| 124 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.43105218 |
| 125 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42348187 |
| 126 | positive regulation of B cell differentiation (GO:0045579) | 2.41297190 |
| 127 | indolalkylamine metabolic process (GO:0006586) | 2.41278279 |
| 128 | triglyceride homeostasis (GO:0070328) | 2.40434998 |
| 129 | acylglycerol homeostasis (GO:0055090) | 2.40434998 |
| 130 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.40278466 |
| 131 | response to thyroid hormone (GO:0097066) | 2.39553834 |
| 132 | positive regulation of interferon-alpha production (GO:0032727) | 2.39264264 |
| 133 | intestinal cholesterol absorption (GO:0030299) | 2.38407813 |
| 134 | fatty acid beta-oxidation (GO:0006635) | 2.37705370 |
| 135 | cellular biogenic amine catabolic process (GO:0042402) | 2.37574505 |
| 136 | amine catabolic process (GO:0009310) | 2.37574505 |
| 137 | response to muramyl dipeptide (GO:0032495) | 2.35977276 |
| 138 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.35532945 |
| 139 | pentose metabolic process (GO:0019321) | 2.35379911 |
| 140 | oxaloacetate metabolic process (GO:0006107) | 2.34974726 |
| 141 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.31434994 |
| 142 | neutrophil activation involved in immune response (GO:0002283) | 2.30484894 |
| 143 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.29486496 |
| 144 | viral transcription (GO:0019083) | 2.28664075 |
| 145 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.28536259 |
| 146 | mature B cell differentiation involved in immune response (GO:0002313) | 2.27432376 |
| 147 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.27191295 |
| 148 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.25331590 |
| 149 | formation of translation preinitiation complex (GO:0001731) | 2.24555843 |
| 150 | detection of bacterium (GO:0016045) | 2.23118413 |
| 151 | cellular response to interleukin-4 (GO:0071353) | 2.22107518 |
| 152 | positive regulation of nuclease activity (GO:0032075) | 2.21090580 |
| 153 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.16837439 |
| 154 | negative regulation of cell killing (GO:0031342) | 2.16837439 |
| 155 | glucose 6-phosphate metabolic process (GO:0051156) | 2.16510102 |
| 156 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.16115339 |
| 157 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.13839698 |
| 158 | regulation of necrotic cell death (GO:0010939) | 2.13439595 |
| 159 | positive regulation of extracellular matrix organization (GO:1903055) | 2.11932877 |
| 160 | negative regulation of cell size (GO:0045792) | 2.11577165 |
| 161 | positive thymic T cell selection (GO:0045059) | 2.11425782 |
| 162 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.10686744 |
| 163 | detection of other organism (GO:0098543) | 2.09655588 |
| 164 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.08921592 |
| 165 | myeloid dendritic cell differentiation (GO:0043011) | 2.08776444 |
| 166 | regulation of monocyte differentiation (GO:0045655) | 2.08616750 |
| 167 | pyrimidine nucleoside salvage (GO:0043097) | 2.07414680 |
| 168 | pyrimidine-containing compound salvage (GO:0008655) | 2.07414680 |
| 169 | regulation of mast cell degranulation (GO:0043304) | 2.06025550 |
| 170 | nucleotide salvage (GO:0043173) | 2.05913896 |
| 171 | protein localization to endosome (GO:0036010) | 2.05888530 |
| 172 | cellular hyperosmotic response (GO:0071474) | 2.05342252 |
| 173 | response to interleukin-4 (GO:0070670) | 2.04900539 |
| 174 | myeloid dendritic cell activation (GO:0001773) | 2.04726857 |
| 175 | regulation of translational fidelity (GO:0006450) | 2.04592689 |
| 176 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.04315572 |
| 177 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.02218802 |
| 178 | regulation of nuclease activity (GO:0032069) | 2.01770711 |
| 179 | positive regulation of antigen processing and presentation (GO:0002579) | 2.01266226 |
| 180 | type I interferon signaling pathway (GO:0060337) | 2.01243665 |
| 181 | cellular response to type I interferon (GO:0071357) | 2.01243665 |
| 182 | amino sugar catabolic process (GO:0046348) | 2.00677108 |
| 183 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.00397385 |
| 184 | tricarboxylic acid metabolic process (GO:0072350) | 1.99636415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.03639352 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.48114018 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.38269353 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.27869864 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.13573491 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.81781539 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.63115978 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.54298954 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42708542 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.26008459 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.19529794 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16369880 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.15026255 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.13697267 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11621060 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04894585 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03549394 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96492154 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92778381 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.91112385 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.88783229 |
| 22 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86525064 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86022587 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.84457570 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84135124 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78488304 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75802639 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70093394 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67401680 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.64931661 |
| 31 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63706015 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63253773 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62901940 |
| 34 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.61728700 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59511377 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57667856 |
| 37 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57320286 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54083722 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52966144 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.50665884 |
| 41 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48297377 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46953510 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46008393 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45717312 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43408078 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41601201 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41434391 |
| 48 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41342367 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41045580 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40360080 |
| 51 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39431619 |
| 52 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39376989 |
| 53 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38424112 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.37448368 |
| 55 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.36521878 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34954733 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34854503 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34141857 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33850984 |
| 60 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33190682 |
| 61 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32893981 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32488277 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.31845052 |
| 64 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31518740 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31246962 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30783740 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.30574554 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28173854 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26162844 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.25303607 |
| 71 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.24387937 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23493357 |
| 73 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.23064602 |
| 74 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22925477 |
| 75 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.22194609 |
| 76 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21977828 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.21872530 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21754108 |
| 79 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.21695508 |
| 80 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20103150 |
| 81 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19870622 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19698505 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18247271 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17079414 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16661916 |
| 86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16449277 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15702530 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15280807 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15098602 |
| 90 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14333630 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13799607 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13786950 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13636864 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13035437 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12864144 |
| 96 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12155564 |
| 97 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.12000213 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11798077 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11333158 |
| 100 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10629353 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10093564 |
| 102 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09651941 |
| 103 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09288094 |
| 104 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08869446 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08073028 |
| 106 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07286348 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06419880 |
| 108 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05544058 |
| 109 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05069232 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04952637 |
| 111 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04805769 |
| 112 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04450425 |
| 113 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.02298841 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02267404 |
| 115 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.01834580 |
| 116 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.01791363 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99522083 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98775738 |
| 119 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98458437 |
| 120 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97879762 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97857548 |
| 122 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97134718 |
| 123 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97006621 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96867844 |
| 125 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95360411 |
| 126 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.94974773 |
| 127 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93928754 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93548202 |
| 129 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93518144 |
| 130 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93024473 |
| 131 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92869824 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91461448 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89983201 |
| 134 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89831621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.44215511 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.44085810 |
| 3 | MP0005365_abnormal_bile_salt | 3.37112353 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.05959045 |
| 5 | MP0009840_abnormal_foam_cell | 2.95381766 |
| 6 | MP0008260_abnormal_autophagy | 2.87124259 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.48392131 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.48012135 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.42140620 |
| 10 | MP0003436_decreased_susceptibility_to | 2.37781470 |
| 11 | MP0005083_abnormal_biliary_tract | 2.36080251 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.34710780 |
| 13 | MP0000685_abnormal_immune_system | 2.26621615 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.23002076 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.03683267 |
| 16 | MP0003252_abnormal_bile_duct | 1.97251058 |
| 17 | MP0009785_altered_susceptibility_to | 1.96412343 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.86031549 |
| 19 | MP0005332_abnormal_amino_acid | 1.84639152 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.77293434 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.76935268 |
| 22 | MP0003303_peritoneal_inflammation | 1.76260834 |
| 23 | MP0005025_abnormal_response_to | 1.75524159 |
| 24 | MP0000609_abnormal_liver_physiology | 1.72877231 |
| 25 | MP0003724_increased_susceptibility_to | 1.71184399 |
| 26 | MP0001800_abnormal_humoral_immune | 1.71067037 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.67239078 |
| 28 | MP0001790_abnormal_immune_system | 1.66062178 |
| 29 | MP0005387_immune_system_phenotype | 1.66062178 |
| 30 | MP0005671_abnormal_response_to | 1.64507846 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.64327490 |
| 32 | MP0002419_abnormal_innate_immunity | 1.62770869 |
| 33 | MP0006082_CNS_inflammation | 1.60979240 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.59165305 |
| 35 | MP0008469_abnormal_protein_level | 1.55713716 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.54642693 |
| 37 | MP0003186_abnormal_redox_activity | 1.53807605 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.51851641 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.51615315 |
| 40 | MP0002723_abnormal_immune_serum | 1.48793411 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.45684823 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.40607725 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.39453770 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.38575683 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.38170149 |
| 46 | MP0001819_abnormal_immune_cell | 1.36994455 |
| 47 | MP0001853_heart_inflammation | 1.36586933 |
| 48 | MP0001873_stomach_inflammation | 1.34820396 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.34812921 |
| 50 | MP0009764_decreased_sensitivity_to | 1.31823166 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.30522994 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.30466823 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28445150 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.28259506 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.28057504 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.27989971 |
| 57 | MP0002398_abnormal_bone_marrow | 1.27817098 |
| 58 | MP0002405_respiratory_system_inflammati | 1.27717667 |
| 59 | MP0003195_calcinosis | 1.27549763 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.27224984 |
| 61 | MP0004947_skin_inflammation | 1.27108679 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.26453032 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.25567048 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.25567048 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.25142339 |
| 66 | MP0003075_altered_response_to | 1.25049903 |
| 67 | MP0001764_abnormal_homeostasis | 1.22484764 |
| 68 | MP0000678_abnormal_parathyroid_gland | 1.22389473 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 1.20344118 |
| 70 | MP0002722_abnormal_immune_system | 1.19684466 |
| 71 | MP0000716_abnormal_immune_system | 1.19196866 |
| 72 | MP0000598_abnormal_liver_morphology | 1.19112178 |
| 73 | MP0000858_altered_metastatic_potential | 1.16449754 |
| 74 | MP0003111_abnormal_nucleus_morphology | 1.15684127 |
| 75 | MP0002429_abnormal_blood_cell | 1.12617579 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.09353939 |
| 77 | MP0009763_increased_sensitivity_to | 1.08530756 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 1.05471435 |
| 79 | MP0008007_abnormal_cellular_replicative | 1.05170459 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.04019729 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 1.03140514 |
| 82 | MP0001849_ear_inflammation | 1.03027236 |
| 83 | MP0005501_abnormal_skin_physiology | 1.02746201 |
| 84 | MP0002136_abnormal_kidney_physiology | 1.02723040 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.00782574 |
| 86 | MP0006054_spinal_hemorrhage | 1.00714079 |
| 87 | MP0000490_abnormal_crypts_of | 1.00677254 |
| 88 | MP0002796_impaired_skin_barrier | 0.95117471 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.94613766 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.92949469 |
| 91 | MP0005023_abnormal_wound_healing | 0.91929919 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.91759535 |
| 93 | MP0003786_premature_aging | 0.89603197 |
| 94 | MP0000604_amyloidosis | 0.88590085 |
| 95 | MP0005165_increased_susceptibility_to | 0.87294967 |
| 96 | MP0002933_joint_inflammation | 0.86865931 |
| 97 | MP0002006_tumorigenesis | 0.85510307 |
| 98 | MP0000313_abnormal_cell_death | 0.85506006 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.84494478 |
| 100 | MP0002132_abnormal_respiratory_system | 0.83694648 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.82622840 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 0.82092443 |
| 103 | MP0004381_abnormal_hair_follicle | 0.81705096 |
| 104 | MP0005451_abnormal_body_composition | 0.81083396 |
| 105 | MP0001756_abnormal_urination | 0.80662210 |
| 106 | MP0009931_abnormal_skin_appearance | 0.80531688 |
| 107 | MP0000343_altered_response_to | 0.80420322 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.79672539 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.79076802 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.78236894 |
| 111 | MP0004957_abnormal_blastocyst_morpholog | 0.77774719 |
| 112 | MP0001663_abnormal_digestive_system | 0.77557818 |
| 113 | MP0002060_abnormal_skin_morphology | 0.77411509 |
| 114 | MP0003866_abnormal_defecation | 0.76732508 |
| 115 | MP0001661_extended_life_span | 0.76009032 |
| 116 | MP0000703_abnormal_thymus_morphology | 0.75661397 |
| 117 | MP0004147_increased_porphyrin_level | 0.72235366 |
| 118 | MP0005166_decreased_susceptibility_to | 0.71212669 |
| 119 | MP0003448_altered_tumor_morphology | 0.70917256 |
| 120 | MP0003011_delayed_dark_adaptation | 0.70433959 |
| 121 | MP0003693_abnormal_embryo_hatching | 0.70245210 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.69383801 |
| 123 | MP0009278_abnormal_bone_marrow | 0.68571204 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.67925032 |
| 125 | MP0005670_abnormal_white_adipose | 0.67868922 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.67817040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.15793250 |
| 2 | Deep venous thrombosis (HP:0002625) | 3.85235377 |
| 3 | Xanthomatosis (HP:0000991) | 3.79897797 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.76822207 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.43868942 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.43868942 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.43868942 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.39912878 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.34761604 |
| 10 | Complement deficiency (HP:0004431) | 3.23172491 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.19517808 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.09555118 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.06613799 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.05939907 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.03671830 |
| 16 | Hyperammonemia (HP:0001987) | 3.01671895 |
| 17 | Joint hemorrhage (HP:0005261) | 3.01523585 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.00747167 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 2.97579856 |
| 20 | Abnormal gallbladder physiology (HP:0012438) | 2.96672974 |
| 21 | Cholecystitis (HP:0001082) | 2.96672974 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96132139 |
| 23 | Vertebral compression fractures (HP:0002953) | 2.95324497 |
| 24 | Abnormality of complement system (HP:0005339) | 2.93153928 |
| 25 | Ragged-red muscle fibers (HP:0003200) | 2.92855519 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89573209 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.88843960 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.87733486 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.83746151 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.81304543 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77162005 |
| 32 | Ketosis (HP:0001946) | 2.70895764 |
| 33 | Obstructive lung disease (HP:0006536) | 2.70405163 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70405163 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 2.67626906 |
| 36 | Hypertensive crisis (HP:0100735) | 2.66610707 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.66593691 |
| 38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.66560946 |
| 39 | Hyperbilirubinemia (HP:0002904) | 2.66293634 |
| 40 | Myocardial infarction (HP:0001658) | 2.63818397 |
| 41 | Loss of speech (HP:0002371) | 2.63803209 |
| 42 | Hepatosplenomegaly (HP:0001433) | 2.57579448 |
| 43 | Petechiae (HP:0000967) | 2.56198225 |
| 44 | Hyperglycinuria (HP:0003108) | 2.53150359 |
| 45 | Thrombocytosis (HP:0001894) | 2.52492381 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.52128339 |
| 47 | Fat malabsorption (HP:0002630) | 2.51299834 |
| 48 | Pustule (HP:0200039) | 2.50003436 |
| 49 | Increased serum ferritin (HP:0003281) | 2.48961627 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47606564 |
| 51 | Colitis (HP:0002583) | 2.44168511 |
| 52 | Microvesicular hepatic steatosis (HP:0001414) | 2.40619579 |
| 53 | Abnormal platelet function (HP:0011869) | 2.38856834 |
| 54 | Impaired platelet aggregation (HP:0003540) | 2.38856834 |
| 55 | Abnormality of iron homeostasis (HP:0011031) | 2.37448944 |
| 56 | Chronic otitis media (HP:0000389) | 2.36390028 |
| 57 | J-shaped sella turcica (HP:0002680) | 2.34436819 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.33891564 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.33753189 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 2.33753189 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.33464759 |
| 62 | Gingival bleeding (HP:0000225) | 2.32289271 |
| 63 | Cellulitis (HP:0100658) | 2.31325844 |
| 64 | Epistaxis (HP:0000421) | 2.30236938 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.29536771 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.29523703 |
| 67 | Hypercholesterolemia (HP:0003124) | 2.29056381 |
| 68 | Nasal polyposis (HP:0100582) | 2.28657859 |
| 69 | Glomerulonephritis (HP:0000099) | 2.26570976 |
| 70 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.24975263 |
| 71 | Myositis (HP:0100614) | 2.24190230 |
| 72 | Abnormality of the intrinsic pathway (HP:0010989) | 2.23230409 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.22722646 |
| 74 | Generalized aminoaciduria (HP:0002909) | 2.21591901 |
| 75 | Steatorrhea (HP:0002570) | 2.20810653 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.20680397 |
| 77 | Agammaglobulinemia (HP:0004432) | 2.19044147 |
| 78 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.17684677 |
| 79 | Polycythemia (HP:0001901) | 2.17539061 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17382320 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.17382320 |
| 82 | Gout (HP:0001997) | 2.17378828 |
| 83 | Recurrent viral infections (HP:0004429) | 2.17206351 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.16438222 |
| 85 | Fatigue (HP:0012378) | 2.15279390 |
| 86 | Hyperglycinemia (HP:0002154) | 2.14999814 |
| 87 | Progressive muscle weakness (HP:0003323) | 2.14126498 |
| 88 | Recurrent skin infections (HP:0001581) | 2.13985278 |
| 89 | Seborrheic dermatitis (HP:0001051) | 2.13886393 |
| 90 | Hypoglycemic coma (HP:0001325) | 2.13552716 |
| 91 | Abnormality of methionine metabolism (HP:0010901) | 2.13299263 |
| 92 | Urticaria (HP:0001025) | 2.12010139 |
| 93 | Poikilocytosis (HP:0004447) | 2.11552579 |
| 94 | Reticulocytosis (HP:0001923) | 2.10346719 |
| 95 | Achilles tendon contracture (HP:0001771) | 2.09916341 |
| 96 | Abnormality of macrophages (HP:0004311) | 2.09488457 |
| 97 | Dysostosis multiplex (HP:0000943) | 2.07325258 |
| 98 | Hypoalphalipoproteinemia (HP:0003233) | 2.06361370 |
| 99 | Rough bone trabeculation (HP:0100670) | 2.06238777 |
| 100 | IgM deficiency (HP:0002850) | 2.05744551 |
| 101 | Nausea (HP:0002018) | 2.05587287 |
| 102 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.05471798 |
| 103 | Prolonged neonatal jaundice (HP:0006579) | 2.05452823 |
| 104 | Recurrent fungal infections (HP:0002841) | 2.05217867 |
| 105 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04765741 |
| 106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04765741 |
| 107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04765741 |
| 108 | Purpura (HP:0000979) | 2.04141228 |
| 109 | Thrombophlebitis (HP:0004418) | 2.03998936 |
| 110 | Abnormality of the Achilles tendon (HP:0005109) | 2.03188275 |
| 111 | Nonimmune hydrops fetalis (HP:0001790) | 2.01318868 |
| 112 | Hepatocellular carcinoma (HP:0001402) | 2.00755592 |
| 113 | Spastic diplegia (HP:0001264) | 1.97017929 |
| 114 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.95255767 |
| 115 | Abnormality of reticulocytes (HP:0004312) | 1.94997623 |
| 116 | Distal lower limb muscle weakness (HP:0009053) | 1.94837716 |
| 117 | Meningitis (HP:0001287) | 1.94485853 |
| 118 | Pancreatitis (HP:0001733) | 1.94246089 |
| 119 | Interstitial pulmonary disease (HP:0006530) | 1.93807988 |
| 120 | Spontaneous hematomas (HP:0007420) | 1.93764627 |
| 121 | Inflammation of the large intestine (HP:0002037) | 1.91721649 |
| 122 | Increased IgE level (HP:0003212) | 1.91344367 |
| 123 | Esophageal varix (HP:0002040) | 1.91109243 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90189843 |
| 125 | Mucopolysacchariduria (HP:0008155) | 1.90189843 |
| 126 | Metabolic acidosis (HP:0001942) | 1.90093660 |
| 127 | Trismus (HP:0000211) | 1.89609578 |
| 128 | Menorrhagia (HP:0000132) | 1.88351379 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87848275 |
| 130 | Abnormality of proline metabolism (HP:0010907) | 1.87135025 |
| 131 | Hydroxyprolinuria (HP:0003080) | 1.87135025 |
| 132 | Vascular calcification (HP:0004934) | 1.86318730 |
| 133 | Acanthocytosis (HP:0001927) | 1.85176342 |
| 134 | Hypertriglyceridemia (HP:0002155) | 1.84425619 |
| 135 | Gastrointestinal stroma tumor (HP:0100723) | 1.83918526 |
| 136 | Polygenic inheritance (HP:0010982) | 1.82360148 |
| 137 | Delayed CNS myelination (HP:0002188) | 1.82292774 |
| 138 | Malnutrition (HP:0004395) | 1.81812606 |
| 139 | Periodontitis (HP:0000704) | 1.81276229 |
| 140 | Axonal loss (HP:0003447) | 1.80749418 |
| 141 | Late onset (HP:0003584) | 1.80682026 |
| 142 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77558126 |
| 143 | Elevated alkaline phosphatase (HP:0003155) | 1.77238676 |
| 144 | Abnormality of the thoracic spine (HP:0100711) | 1.75094470 |
| 145 | Amyloidosis (HP:0011034) | 1.74175789 |
| 146 | Thoracic kyphosis (HP:0002942) | 1.73682784 |
| 147 | Villous atrophy (HP:0011473) | 1.73385410 |
| 148 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73385410 |
| 149 | Abnormal trabecular bone morphology (HP:0100671) | 1.71867831 |
| 150 | Distal upper limb amyotrophy (HP:0007149) | 1.71655858 |
| 151 | Upper limb amyotrophy (HP:0009129) | 1.71655858 |
| 152 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70847919 |
| 153 | Cholelithiasis (HP:0001081) | 1.70473717 |
| 154 | Abnormality of glycolysis (HP:0004366) | 1.68242837 |
| 155 | Distal lower limb amyotrophy (HP:0008944) | 1.68063895 |
| 156 | Prolonged bleeding time (HP:0003010) | 1.67558353 |
| 157 | Progressive neurologic deterioration (HP:0002344) | 1.67528087 |
| 158 | Gastrointestinal infarctions (HP:0005244) | 1.66885617 |
| 159 | Granulocytopenia (HP:0001913) | 1.64841005 |
| 160 | Rhabdomyolysis (HP:0003201) | 1.63007570 |
| 161 | Abnormality of T cell physiology (HP:0011840) | 1.61605757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.24058838 |
| 2 | MAP4K1 | 3.42001875 |
| 3 | BCKDK | 3.25436185 |
| 4 | TRIB3 | 2.90389295 |
| 5 | TBK1 | 2.71943578 |
| 6 | SMG1 | 2.69297772 |
| 7 | NME2 | 2.69113362 |
| 8 | PRPF4B | 2.56186190 |
| 9 | TYK2 | 2.44071455 |
| 10 | PKN2 | 2.29484051 |
| 11 | PIM2 | 2.17767893 |
| 12 | BLK | 2.17402538 |
| 13 | FGFR4 | 2.07039377 |
| 14 | ZAP70 | 2.01594173 |
| 15 | EIF2AK1 | 1.89892212 |
| 16 | IKBKE | 1.87429286 |
| 17 | MAP3K14 | 1.75236710 |
| 18 | RIPK4 | 1.74667252 |
| 19 | FLT3 | 1.69714099 |
| 20 | MAP3K10 | 1.68123276 |
| 21 | MAP2K3 | 1.68101435 |
| 22 | TAOK3 | 1.67462333 |
| 23 | IRAK4 | 1.67108559 |
| 24 | ICK | 1.62246457 |
| 25 | KIT | 1.61603758 |
| 26 | VRK2 | 1.59968085 |
| 27 | IRAK3 | 1.57688465 |
| 28 | JAK3 | 1.57488069 |
| 29 | GRK6 | 1.57150449 |
| 30 | TXK | 1.54010866 |
| 31 | STK10 | 1.52931221 |
| 32 | MAP3K11 | 1.50174167 |
| 33 | TGFBR2 | 1.50105038 |
| 34 | KDR | 1.50058399 |
| 35 | BUB1 | 1.49580673 |
| 36 | BTK | 1.46235981 |
| 37 | EEF2K | 1.41578722 |
| 38 | LRRK2 | 1.39173026 |
| 39 | SIK1 | 1.36747123 |
| 40 | NEK9 | 1.34910598 |
| 41 | TESK2 | 1.33445029 |
| 42 | EPHA2 | 1.29607791 |
| 43 | PDK2 | 1.27927209 |
| 44 | RPS6KA4 | 1.25151662 |
| 45 | IKBKB | 1.24353326 |
| 46 | CSF1R | 1.21598283 |
| 47 | JAK1 | 1.14861841 |
| 48 | ARAF | 1.11995742 |
| 49 | SIK3 | 1.10037168 |
| 50 | CSK | 1.09069146 |
| 51 | PIM1 | 1.08336153 |
| 52 | MAP3K3 | 1.03246003 |
| 53 | TLK1 | 0.99769912 |
| 54 | SYK | 0.99743533 |
| 55 | PTK6 | 0.98713284 |
| 56 | MAPK11 | 0.97973701 |
| 57 | EPHA3 | 0.96301397 |
| 58 | ITK | 0.93674248 |
| 59 | TEC | 0.92296968 |
| 60 | JAK2 | 0.88996245 |
| 61 | PAK4 | 0.85030654 |
| 62 | MAP3K1 | 0.84545244 |
| 63 | EPHB1 | 0.83445930 |
| 64 | TESK1 | 0.83356562 |
| 65 | PIK3CG | 0.83030043 |
| 66 | SCYL2 | 0.81372201 |
| 67 | PDPK1 | 0.76384309 |
| 68 | CHUK | 0.76050986 |
| 69 | LCK | 0.75433000 |
| 70 | CDK12 | 0.74054855 |
| 71 | LYN | 0.73748801 |
| 72 | CDK4 | 0.73570010 |
| 73 | NEK2 | 0.71079928 |
| 74 | MAP3K8 | 0.70027857 |
| 75 | NME1 | 0.67433398 |
| 76 | DAPK1 | 0.66916425 |
| 77 | MAPKAPK3 | 0.65586834 |
| 78 | DYRK1B | 0.65556620 |
| 79 | HCK | 0.65545300 |
| 80 | TAOK2 | 0.65104636 |
| 81 | MATK | 0.63407861 |
| 82 | FGFR3 | 0.63308047 |
| 83 | TAOK1 | 0.63298228 |
| 84 | STK4 | 0.62091740 |
| 85 | MST1R | 0.60035137 |
| 86 | CDK7 | 0.59495122 |
| 87 | CDC42BPA | 0.58308071 |
| 88 | ABL2 | 0.58283128 |
| 89 | TTN | 0.57714216 |
| 90 | CDK8 | 0.57381294 |
| 91 | MAP2K2 | 0.56976049 |
| 92 | SIK2 | 0.56536690 |
| 93 | RPS6KA6 | 0.54528155 |
| 94 | BMX | 0.53983336 |
| 95 | ILK | 0.53127765 |
| 96 | PRKD2 | 0.51571936 |
| 97 | MAPK4 | 0.50462280 |
| 98 | MARK3 | 0.49703236 |
| 99 | CDK6 | 0.49617990 |
| 100 | STK16 | 0.49068114 |
| 101 | MAP3K7 | 0.48009452 |
| 102 | ACVR1B | 0.47903718 |
| 103 | MAP3K5 | 0.47569710 |
| 104 | IRAK2 | 0.47220735 |
| 105 | PDK1 | 0.46804384 |
| 106 | DAPK3 | 0.46049009 |
| 107 | RPS6KC1 | 0.44431973 |
| 108 | RPS6KL1 | 0.44431973 |
| 109 | RIPK1 | 0.42734120 |
| 110 | BRAF | 0.41678407 |
| 111 | TGFBR1 | 0.41059181 |
| 112 | FGR | 0.39126531 |
| 113 | MTOR | 0.39106006 |
| 114 | EIF2AK3 | 0.38582024 |
| 115 | ALK | 0.38308683 |
| 116 | MAPKAPK2 | 0.38201610 |
| 117 | MAP3K13 | 0.36370685 |
| 118 | TNK2 | 0.35143757 |
| 119 | AURKA | 0.34854777 |
| 120 | PAK1 | 0.34348978 |
| 121 | HIPK2 | 0.34099140 |
| 122 | NLK | 0.33049309 |
| 123 | IRAK1 | 0.32116841 |
| 124 | MAPK12 | 0.30976194 |
| 125 | PRKCD | 0.30332015 |
| 126 | DYRK3 | 0.28945086 |
| 127 | MAP2K6 | 0.28896415 |
| 128 | CLK1 | 0.27351138 |
| 129 | PRKG2 | 0.26938669 |
| 130 | FES | 0.26126759 |
| 131 | RPS6KB2 | 0.25321053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.06905932 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.80412238 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.53586522 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22220533 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.15672500 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11336959 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06700947 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02531321 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97629701 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96543054 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91417050 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.87273804 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82179528 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.69510130 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69381623 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.67553571 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62850638 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62341290 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.58451454 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57679388 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55369334 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53804742 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48360386 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42579968 |
| 25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.38199452 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37224945 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35700368 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33242493 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32913889 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28554783 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27534912 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27147496 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.25112661 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24739016 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24107125 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.23989328 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21687331 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21395787 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20456036 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18924458 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16883646 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15113883 |
| 43 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15111958 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.12470437 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.10697877 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10481906 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.09892022 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08593093 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06789370 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06555176 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05888416 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05400811 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04873209 |
| 54 | Ribosome_Homo sapiens_hsa03010 | 1.03722367 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03441758 |
| 56 | Asthma_Homo sapiens_hsa05310 | 1.02808359 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02144833 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00260920 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.98964695 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97731999 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95946061 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95582464 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95182301 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94058452 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93634663 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92671832 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90917583 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90822362 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.90415370 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90225504 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.90013455 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89394151 |
| 73 | Measles_Homo sapiens_hsa05162 | 0.87642001 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87147549 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.86841838 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86704992 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86070976 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.85770345 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83456727 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82588435 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82561358 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82497623 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81754705 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81474215 |
| 85 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81391581 |
| 86 | DNA replication_Homo sapiens_hsa03030 | 0.79868767 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79333503 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78984180 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76937348 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76004158 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.75936503 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.73680526 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.73247435 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.71489673 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70905710 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70648279 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70630613 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70615439 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.69066272 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.67534584 |
| 101 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66793636 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66615296 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65450453 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65333816 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64551045 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63637417 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63444248 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63185394 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.62940015 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62919354 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62798880 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62726785 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62714875 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.61124118 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59303795 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57271623 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.57062031 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57047154 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56373104 |
| 120 | Base excision repair_Homo sapiens_hsa03410 | 0.56281406 |
| 121 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56098895 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54778623 |
| 123 | Mismatch repair_Homo sapiens_hsa03430 | 0.53503186 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53483623 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53164869 |
| 126 | Proteasome_Homo sapiens_hsa03050 | 0.52309168 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49781247 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48871713 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48788774 |
| 130 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47689365 |
| 131 | Malaria_Homo sapiens_hsa05144 | 0.47235984 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46384979 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45192034 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44572631 |
| 135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44566971 |
| 136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44528340 |
| 137 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44523870 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42729615 |
| 139 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41554899 |
| 140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41351210 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.40457606 |
| 142 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39340158 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.38708845 |

